Zenas BioPharma, Inc. Quarterly Operating Lease, Liability in USD for Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Zenas BioPharma, Inc. quarterly Operating Lease, Liability history and growth rate for Q3 2024.
Zenas BioPharma, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $384M.

Operating Lease, Liability, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$384M			Sep 30, 2024	10-Q	2024-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.